SCHEMBL13611335

SCHEMBL13611335

O=C=Nc1ccc(C(=O)OCC(=O)OCC(COC(=O)COC(=O)c2ccc(N=C=O)cc2)OC(=O)COC(=O)c2ccc(N=C=O)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.40
SERPINE1 P05121 1/20 0.38
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN11 Q06124 1/20 0.35
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33
GAA P10253 2/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
ALDH1A1 P00352 3/20 0.32
NPY1R P25929 1/20 0.32
NPY2R P49146 1/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13624648 0.92 ADRB2 (0.41) PTPN1SERPINE1TSHRMAPTALDH1A1
SCHEMBL13624651 0.92 ADRB2 (0.41) PTPN1SERPINE1TSHRMAPTALDH1A1
SCHEMBL14802505 0.90 PTPN1 (0.33) PTPN1SERPINE1GAAALDH1A1
SCHEMBL13611320 0.83 TSHR (0.41) SERPINE1CYP3A4TSHRPRSS1PRSS2
SCHEMBL13611326 0.81 PRSS1 (0.45) SERPINE1CYP3A4TSHRPRSS1PRSS2
SCHEMBL13611354 0.81 PRSS1 (0.47) SERPINE1CYP3A4TSHRPRSS1PRSS2
SCHEMBL13611334 0.80 MAPK1 (0.45) CYP3A4TSHRPRSS1PRSS2PRSS3
SCHEMBL13611328 0.80 SERPINE1 (0.40) SERPINE1CYP3A4TSHRPRSS1PRSS2
SCHEMBL13611329 0.80 PRSS1 (0.44) SERPINE1CYP3A4TSHRPRSS1PRSS2
SCHEMBL11956794 0.79 LMNA (0.50) PTPN1SERPINE1CYP3A4TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130078300-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF BEZWADA BIOMEDICAL, LLC (US) 2013-03-28 US disclosed
US-8367747-B2 Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2013-02-05 US disclosed
US-8367747-B2 Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2013-02-05 US disclosed
US-20090292029-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF BEZWADA BIOMEDICAL, L.L.C (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292029-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF PUF60, PFAS, UROD PTPN1 4399/4885SERPINE1 2218/4885CYP3A4 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.